Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
Preclinical Evaluation of the Multiple Tyrosine Kinases Inhibitor Anlotinib in Leukemia Stem Cells.
Pharmaceuticals (Basel). 2022 Oct 25;15(11):1313. doi: 10.3390/ph15111313.
Pharmaceuticals (Basel). 2022.
PMID: 36355485
Free PMC article.
Therapeutic synergy of Triptolide and MDM2 inhibitor against acute myeloid leukemia through modulation of p53-dependent and -independent pathways.
Chen Q, Deng S, Deng M, Shi Y, Zhong M, Ding L, Jiang Y, Zhou Y, Carter BZ, Xu B.
Chen Q, et al.
Exp Hematol Oncol. 2022 Apr 16;11(1):23. doi: 10.1186/s40164-022-00276-z.
Exp Hematol Oncol. 2022.
PMID: 35429966
Free PMC article.
Item in Clipboard
Cite
Cite